OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2025
(2)
2023
(2)
2024
(1)
2021
(1)
2015
(1)
2014
(1)
2010
(1)
1999
(1)
1998
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Repair of DNA double-strand breaks following UV damage in three Sulfolobus solfataricus strains.
Not available
S-EPMC2944543
|
biostudies-literature
Cite
Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.
Not available
S-EPMC10970485
|
biostudies-literature
Cite
Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease.
Not available
S-EPMC9880878
|
biostudies-literature
Cite
A signature for immune response correlates with HCV treatment outcome in Caucasian subjects.
Not available
S-EPMC4510051
|
biostudies-literature
Cite
Molecular characterization of the alpha-glucosidase gene (malA) from the hyperthermophilic archaeon Sulfolobus solfataricus.
Not available
S-EPMC107019
|
biostudies-literature
Cite
Coordinate transcriptional control in the hyperthermophilic archaeon Sulfolobus solfataricus.
Not available
S-EPMC93880
|
biostudies-literature
Cite
Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors.
Not available
S-EPMC11717987
|
biostudies-literature
Cite
Radiomic phenotypes of oligometastatic non-small cell lung cancer.
Not available
S-EPMC12541869
|
biostudies-literature
Cite
Modeling viral evolutionary dynamics after telaprevir-based treatment.
Not available
S-EPMC4138032
|
biostudies-literature
Cite
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.
Not available
S-EPMC7924576
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets